Systematic Review with Network Meta-Analysis: Efficacy of Induction Therapy with a Second Biological Agent in Anti-TNF-Experienced Crohn’s Disease Patients

Vedolizumab for the treatment of Crohn’s disease

(2018) Marjorie Argollo et al.   Expert Review of Clinical Immunology

Top-down approach to biological therapy of Crohn’s disease

(2017) Simon Hirschmann et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

Natalizumab in the treatment of Crohn’s disease patients

(2017) Cristiano Pagnini et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

Primary and secondary nonresponse to infliximab: mechanisms and countermeasures

(2017) Uni Wong et al.   Expert Opinion on Drug Metabolism & Toxicology

Ustekinumab and Anti-Interleukin-23 Agents in Crohn's Disease

(2017) Parakkal Deepak et al.   GASTROENTEROLOGY CLINICS OF NORTH AMERICA

Vedolizumab Induces Long-term Mucosal Healing in Patients With Crohn’s Disease and Ulcerative Colitis

(2017) Maja Noman et al.   Journal of Crohns & Colitis

Systematic review with meta-analysis: the efficacy of a second anti-TNF in patients with inflammatory bowel disease whose previous anti-TNF treatment has failed

(2015) J. P. Gisbert et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Biologic agents for IBD: practical insights

(2015) Silvio Danese et al.   Nature Reviews Gastroenterology & Hepatology

Systematic review with network meta-analysis: the efficacy of anti-TNF agents for the treatment of Crohn's disease

(2014) R. W. Stidham et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Review article: anti-adhesion therapies for inflammatory bowel disease

(2014) T. Lobatón et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Catching the Therapeutic Window of Opportunity in Early Crohn’s Disease

(2014) Silvio Danese et al.   CURRENT DRUG TARGETS

Effects of Vedolizumab Induction Therapy for Patients With Crohn’s Disease in Whom Tumor Necrosis Factor Antagonist Treatment Failed

(2014) Bruce E. Sands et al.   GASTROENTEROLOGY

Comparative Efficacy of Biologic Therapy in Biologic-Naïve Patients With Crohn Disease: A Systematic Review and Network Meta-analysis

(2014) Siddharth Singh et al.   MAYO CLINIC PROCEEDINGS

Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement

(2013) David Moher   ANNALS OF INTERNAL MEDICINE

Optimizing anti-TNF treatments in inflammatory bowel disease

(2013) Shomron Ben-Horin et al.   AUTOIMMUNITY REVIEWS

Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease

(2013) William J. Sandborn et al.   NEW ENGLAND JOURNAL OF MEDICINE

Graphical Tools for Network Meta-Analysis in STATA

(2013) Anna Chaimani et al.   PLoS One

Crohn's disease

(2012) Daniel C Baumgart et al.   LANCET

Ustekinumab Induction and Maintenance Therapy in Refractory Crohn's Disease

(2012) William J. Sandborn et al.   NEW ENGLAND JOURNAL OF MEDICINE

Emerging Biologics in the Treatment of Inflammatory Bowel Disease: What is Around the Corner?

(2010) Gionata Fiorino et al.   CURRENT DRUG TARGETS

The potential for disease modification in Crohn's disease

(2010) G. Van Assche et al.   Nature Reviews Gastroenterology & Hepatology

Inflammatory Bowel Disease

(2009) Clara Abraham et al.   NEW ENGLAND JOURNAL OF MEDICINE

A Randomized Trial of Ustekinumab, a Human Interleukin-12/23 Monoclonal Antibody, in Patients With Moderate-to-Severe Crohn's Disease

(2008) William J. Sandborn et al.   GASTROENTEROLOGY